We are live on ! Find out more
EDIT icon

Editas Medicine
EDIT

239 hedge funds and large institutions have $1.55B invested in Editas Medicine in 2020 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 84 increasing their positions, 58 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed

132% more call options, than puts

Call options by funds: $33.3M | Put options by funds: $14.3M

45% more repeat investments, than reductions

Existing positions increased: 84 | Existing positions reduced: 58

2% more first-time investments, than exits

New positions opened: 44 | Existing positions closed: 43

0% more funds holding

Funds holding: 238 → 239 (+1)

0.24% less ownership

Funds ownership: 88.82% → 88.57% (-0.24%)

4% less capital invested

Capital invested by funds: $1.61B → $1.55B (-$61M)

Holders
239
Holders Change
+1
Holders Change %
+0.42%
% of All Funds
4.82%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
44
Increased
84
Reduced
58
Closed
43
Calls
$33.3M
Puts
$14.3M
Net Calls
+$19M
Net Calls Change
-$15.2M

Top Buyers

Rank Fund Capital Flow
1
AIM
ARK Investment Management
Florida
+$102M
2
BlackRock
BlackRock
New York
+$16.6M
3
Goldman Sachs
Goldman Sachs
New York
+$7.05M
4
SOMRS
State of Michigan Retirement System
Michigan
+$6.39M
5
N
Nuveen
North Carolina
+$5.63M

Top Sellers

Rank Fund Capital Flow
1
CCM
CAAS Capital Management
New York
-$41.3M
2
APM
Avidity Partners Management
Texas
-$17.7M
3
Viking Global Investors
Viking Global Investors
Connecticut
-$12.2M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$9.04M
5
State Street
State Street
Massachusetts
-$5.64M
Name Holding Trade Value Shares
Change 		Change in
Stake
AIM
1
ARK Investment Management
Florida
$299M +$102M +3,124,278 +41%
Vanguard Group
2
Vanguard Group
Pennsylvania
$160M -$1.71M -52,437 -0.9%
BlackRock
3
BlackRock
New York
$154M +$16.6M +510,595 +10%
Sumitomo Mitsui Trust Group
4
Sumitomo Mitsui Trust Group
Japan
$142M +$2.48M +76,279 +2%
NAMA
5
Nikko Asset Management Americas
New York
$142M +$2.64M +81,053 +2%
State Street
6
State Street
Massachusetts
$81.6M -$5.64M -173,136 -6%
Capital World Investors
7
Capital World Investors
California
$49.4M – – –
Federated Hermes
8
Federated Hermes
Pennsylvania
$47.9M +$65.1K +2,000 +0.1%
Chevy Chase Trust
9
Chevy Chase Trust
Maryland
$36.2M +$5.38M +165,274 +15%
Morgan Stanley
10
Morgan Stanley
New York
$30.2M +$2.81M +86,229 +9%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$28M -$9.04M -277,634 -22%
Goldman Sachs
12
Goldman Sachs
New York
$27.8M +$7.05M +216,473 +28%
DM
13
Deerfield Management
New York
$27.7M -$5.54M -170,000 -15%
CS
14
Credit Suisse
Switzerland
$27.3M -$1.47M -45,033 -4%
Geode Capital Management
15
Geode Capital Management
Massachusetts
$26.1M +$1.35M +41,513 +5%
Northern Trust
16
Northern Trust
Illinois
$22.3M +$1.01M +31,041 +4%
Two Sigma Advisers
17
Two Sigma Advisers
New York
$17.8M +$879K +27,000 +4%
Norges Bank
18
Norges Bank
Norway
$16.7M -$1.99M -61,008 -9%
JP Morgan Chase
19
JP Morgan Chase
New York
$13.4M +$3.24M +99,356 +27%
N
20
Nuveen
North Carolina
$13.2M +$5.63M +172,940 +58%
Charles Schwab
21
Charles Schwab
California
$11.4M +$454K +13,935 +4%
Two Sigma Investments
22
Two Sigma Investments
New York
$10.8M -$2.78M -85,291 -18%
American Century Companies
23
American Century Companies
Missouri
$8.15M – – –
SBH
24
Segall Bryant & Hamill
Illinois
$7.17M +$376K +11,549 +5%
Bank of New York Mellon
25
Bank of New York Mellon
New York
$7.01M -$2.17M -66,582 -21%
1
2 3 4 5

EDIT Hedge Fund Activity: Q3 2020 in Review

239 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Editas Medicine (EDIT) for Q3 2020, worth a combined $1.55B — down 3.8% from $1.61B a quarter earlier.

Buyers outnumbered sellers: 44 funds opened new EDIT positions and 43 closed out — a net gain of 1 holder — while 84 added to existing stakes and 58 trimmed.

The largest buyer was ARK Investment Management, adding an estimated $102M. The largest seller was CAAS Capital Management, exiting entirely with an estimated $41.3M sold.

  • 239 institutional investors held Editas Medicine (EDIT) as of Q3 2020, up from 238 in Q2 2020.
  • Funds reported $1.55B of Editas Medicine stock for Q3 2020, down 3.8% quarter-over-quarter.
  • 44 funds opened new Editas Medicine positions in Q3 2020 and 43 closed out, a net change of +1 holder.
  • The largest Editas Medicine buyer in Q3 2020 was ARK Investment Management, an estimated $102M added.
  • The largest Editas Medicine seller in Q3 2020 was CAAS Capital Management, an estimated $41.3M sold.

Based on aggregated 13F filings for Q3 2020.